Study of BGB-A317 in Participants With Previously Treated Unresectable HCC | BeOne Medicines

Study of BGB-A317 in Participants With Previously Treated Unresectable HCC

Beigene Study ID

BGB-A317-208

ClinicalTrials.gov ID

NCT03419897

EudraCT Number

2017-003983-10

China Drug Trials ID

CTR20171257

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan